| 000 | 01352 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513203756.0 | ||
| 264 | 0 | _c20000404 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0002-9394 | ||
| 024 | 7 |
_a10.1016/s0002-9394(99)00350-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSkolnick, C A | |
| 245 | 0 | 0 |
_aTissue plasminogen activator to treat impending pupillary block glaucoma in patients with acute fibrinous HLA-B27 positive iridocyclitis. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cMar 2000 |
||
| 300 |
_a363-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aFibrin _xdrug effects |
| 650 | 0 | 4 |
_aFibrinolysis _xdrug effects |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aGlaucoma _xetiology |
| 650 | 0 | 4 |
_aHLA-B27 Antigen _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIridocyclitis _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPupil Disorders _xetiology |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 700 | 1 | _aFiscella, R G | |
| 700 | 1 | _aTessler, H H | |
| 700 | 1 | _aGoldstein, D A | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 129 _gno. 3 _gp. 363-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9394(99)00350-5 _zAvailable from publisher's website |
| 999 |
_c10658614 _d10658614 |
||